梅花生物：梅花生物2024年年度报告（英文版）.PDF

1、Meihua Holdings Group Co.,Ltd.Annual Report 20241/281Company Code:600873Short name:Meihua BioMeihua Holdings Group Co.,Ltd.Annual Report 2024This is an English translation from the Annual Report 2024,in case of anyinconsistency,the Chinese Version shall prevail.Meihua Holdings Group Co.,Ltd.Annual R

2、eport 20242/281Important InformationI.The Companys board of directors,board of supervisors,directors,supervisors,and officersguarantee that the contents of this annual report are true,accurate,and complete without any falserecords,misleading statements,or material omissions and bear joint and severa

3、l legal liability.II.All of the Companys directors have attended the board meeting.III.Zandar(Shenzhen)CPAs LLP(Special General Partnership)(formerly known as Da HuaCPAs LLP(Special General Partnership)has issued an unqualified audit report for the Company.IV.Wang Aijun,the principal of the Company,

4、Wang Lihong,the accounting principal,and WangAiling,the principal of the accounting body(the accounting officer),hereby declare that theyguarantee the truthfulness,accuracy,and completeness of the financial report in the annual report.V.Profit distribution plan or capital reserve conversion plan for

5、 the Reporting Period as approvedby the BoardUpon deliberation and approval of the 18thmeeting of the 10thsession of the board of directors,theprofit distribution plan(proposal)for 2024 is as follows:The Company plans to distribute cash dividendsbased on the total share capital registered on the equ

6、ity distribution record date(after deducting shares inthe share repurchase account).A cash dividend of 0.4206 yuan per share(inclusive of tax)will bedistributed to all shareholders.As of December 31,2024,the Company had a total share capital of2,852,788,750 shares,based on which the estimated total